Partnership provides bring your own device ‘BYOD’ virtual care solution to patients with diabetes
New York, New York and Mountain View, California – July 7, 2016 – AMC Health, the leading provider of proven remote patient monitoring and engagement solutions that are exclusively endorsed by the American Hospital Association, and Glooko Inc., the leading population health platform for diabetes management, today announced a partnership to help clinicians and patients improve diabetes outcomes at lower costs.
Glooko is one of many FDA 510(k) cleared devices now integrated into AMC Health’s expanding FDA-cleared CareConsole® virtual care platform. Glooko is currently being used in 1,000+ health systems, health plans and employers in the USA, including Joslin Diabetes Center, Stanford Health, and Atrius Health in Boston. Glooko’s HIPAA-compliant solution enables easy downloading of information from over 50 of the most popular blood glucose meters, insulin pumps, and continuous glucose monitors (CGMs). Glooko enables individuals to download and add context to their data through its award-winning diabetes mobile application. Adding Glooko to the AMC Health CareConsole® platform with robust decision support analytics provides healthcare organizations tools to better optimize their clinical impact in diabetes populations.
“Glooko will be joining AMC Health’s extensive ecosystem of healthcare technology partners that have chosen to integrate into AMC Health’s CareConsole® virtual care platform. This partnership with Glooko will give patients the flexibility of using their existing glucometers and support stronger connections with their clinical teams on a real-time basis, while also expanding care beyond the walls of hospitals, doctors’ offices and outpatient settings,” said Nesim Bildirici, founder and CEO of AMC Health. “Our clinically proven solutions, and clinical, technology and analytics expertise, gained over millions of patient days, ensure that our solutions promote patient engagement, improve patient outcomes, and prevent costly acute episodes.”
AMC Health has been performing groundbreaking work in remote patient monitoring and engagement since its founding in 2002, and has consistently partnered with organizations to assist with the identification of patients with the highest risks, likelihood of hospitalizations, and utilization of services. AMC Health has demonstrated, in peer-reviewed clinical studies , that its remote patient monitoring and engagement solutions have reduced hospital readmissions for patients with heart failure and reduced their cost of care. AMC Health solutions have also helped patients with diabetes significantly reduce their HbA1c levels and patients with hypertension substantially reduce and control their blood pressure. These results have been published in the Journal of the American Medical Association (JAMA), Journal of Managed Care Medicine , Medical Care and Population Health Management.
“Glooko’s partnership with AMC Health means health systems, health plans, and employers will be able to ramp diabetes-focused programs using Glooko more quickly by leveraging AMC Health’s remote monitoring & population management expertise” said Rick Altinger, Glooko’s CEO. “Organizations using AMC Health’s suite of disease management tools addressing heart disease, hypertension and obesity can now access Glooko’s best-in-class platform for remotely monitoring blood glucose, a key biometric in managing those conditions.”
About AMC Health
AMC Health is the leading provider of virtual care solutions. AMC Health customers use these proven solutions to promote patient engagement, improve patient outcomes, and prevent costly acute episodes. AMC Health’s FDA-cleared remote patient engagement solution is powered by CareConsole®, an open web-based platform, which integrates seamlessly with biometric monitoring devices and other technologies so a care team can monitor patients’ chronic conditions and adherence to a care plan wherever they might be. Our customers have demonstrated through large published peer-reviewed studies across various disease states that outcomes can be improved significantly through connecting patients to their clinical teams on a real-time basis and expanding care beyond the walls of hospitals, doctors’ offices and outpatient settings. The published studies highlight improved care management, reduced medical costs and hospital readmissions, and a 3:1 or greater return on investment. AMC Health’s remote patient monitoring and engagement solutions have earned the exclusive endorsement of the American Hospital Association. For more information, visit www.amchealth.com.
Glooko is the world’s leading Unified Platform for Diabetes Management and is trusted by the world’s leaders in diabetes care. Glooko provides an FDA-cleared, HIPAA-compliant web and mobile application, which aims to improve health outcomes for people with diabetes, in turn reducing costs for payers and the healthcare system. Glooko seamlessly syncs with over 50 blood glucose meters, pumps, CGMs, fitness and activity trackers, and supplies timely, verified patient data such as blood glucose, carbs, insulin, blood pressure, diet and weight data. Glooko’s mobile app enables patients to easily track and proactively manage all aspects of their diabetes care. Glooko’s Population Management web app and API’s offers diabetes-centric analytics and supply insightful reports, graphs and risk flags to patients, health systems and payers, as well as third party developers. Learn more at https://glooko.com, and follow us at twitter.com/GlookoInc and facebook.com/Glooko.
Tweet this: @AMCHealth and @GlookoInc partnership provides #BYOD #virtualcare solution to improve diabetes outcomes | #remotepatientmonitoring #telehealth